219 related articles for article (PubMed ID: 10484860)
1. Cardiac pacemakers and implantable defibrillators in terminal care.
Braun TC; Hagen NA; Hatfield RE; Wyse DG
J Pain Symptom Manage; 1999 Aug; 18(2):126-31. PubMed ID: 10484860
[TBL] [Abstract][Full Text] [Related]
2. Ethical analysis of withdrawal of pacemaker or implantable cardioverter-defibrillator support at the end of life.
Mueller PS; Hook CC; Hayes DL
Mayo Clin Proc; 2003 Aug; 78(8):959-63. PubMed ID: 12911044
[TBL] [Abstract][Full Text] [Related]
3. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness. An ethical distinction.
Kay GN; Bittner GT
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):336-9; discussion 339. PubMed ID: 19808484
[No Abstract] [Full Text] [Related]
4. Perspectives on withdrawing pacemaker and implantable cardioverter-defibrillator therapies at end of life: results of a survey of medical and legal professionals and patients.
Kapa S; Mueller PS; Hayes DL; Asirvatham SJ
Mayo Clin Proc; 2010 Nov; 85(11):981-90. PubMed ID: 20843982
[TBL] [Abstract][Full Text] [Related]
5. Deactivating implanted cardiac devices in terminally ill patients: practices and attitudes.
Mueller PS; Jenkins SM; Bramstedt KA; Hayes DL
Pacing Clin Electrophysiol; 2008 May; 31(5):560-8. PubMed ID: 18439169
[TBL] [Abstract][Full Text] [Related]
6. Palliative Care Consultation and Associated End-of-Life Care After Pacemaker or Implantable Cardioverter-Defibrillator Deactivation.
Pasalic D; Gazelka HM; Topazian RJ; Buchhalter LC; Ottenberg AL; Webster TL; Swetz KM; Mueller PS
Am J Hosp Palliat Care; 2016 Dec; 33(10):966-971. PubMed ID: 26169518
[TBL] [Abstract][Full Text] [Related]
7. Should implantable cardioverter-defibrillators and permanent pacemakers in patients with terminal illness be deactivated? Deactivating permanent pacemaker in patients with terminalillness. Patient autonomy is paramount.
Zellner RA; Aulisio MP; Lewis WR
Circ Arrhythm Electrophysiol; 2009 Jun; 2(3):340-4; discussion 340. PubMed ID: 19808485
[No Abstract] [Full Text] [Related]
8. Considerations in Patients With Cardiac Implantable Electronic Devices at End of Life.
Gura MT
AACN Adv Crit Care; 2015; 26(4):356-63. PubMed ID: 26484996
[TBL] [Abstract][Full Text] [Related]
9. Medicolegal issues arising when pacemaker and implantable cardioverter defibrillator devices are deactivated in terminally ill patients.
McGeary A; Eldergill A
Med Sci Law; 2010 Jan; 50(1):40-4. PubMed ID: 20349694
[TBL] [Abstract][Full Text] [Related]
10. Cardiac Implantable Electronic Devices and End-of-Life Care: An Australian Perspective.
Alhammad NJ; O'Donnell M; O'Donnell D; Mariani JA; Gould PA; McGavigan AD
Heart Lung Circ; 2016 Aug; 25(8):814-9. PubMed ID: 27320854
[TBL] [Abstract][Full Text] [Related]
11. Original research: deactivation of ICDs at the end of life: a systematic review of clinical practices and provider and patient attitudes.
Russo JE
Am J Nurs; 2011 Oct; 111(10):26-35. PubMed ID: 21926561
[TBL] [Abstract][Full Text] [Related]
12. Deactivation of pacemakers and implantable cardioverter-defibrillators.
Kramer DB; Mitchell SL; Brock DW
Prog Cardiovasc Dis; 2012; 55(3):290-9. PubMed ID: 23217433
[TBL] [Abstract][Full Text] [Related]
13. A literature review comparing the experiences and emergent needs of adult patients with permanent pacemakers (PPMs) and implantable cardioverter defibrillators (ICDs).
Tagney J
J Clin Nurs; 2010 Aug; 19(15-16):2081-9. PubMed ID: 20477907
[TBL] [Abstract][Full Text] [Related]
14. Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry.
Gadler F; Valzania C; Linde C
Europace; 2015 Jan; 17(1):69-77. PubMed ID: 25336667
[TBL] [Abstract][Full Text] [Related]
15. Pacemakers and implantable cardioverter defibrillators--general and anesthetic considerations.
Rapsang AG; Bhattacharyya P
Braz J Anesthesiol; 2014; 64(3):205-14. PubMed ID: 24907883
[TBL] [Abstract][Full Text] [Related]
16. Quality of life and end-of-life issues for older patients with implanted cardiac rhythm devices.
Lampert R
Clin Geriatr Med; 2012 Nov; 28(4):693-702. PubMed ID: 23101578
[TBL] [Abstract][Full Text] [Related]
17. Interactions between transvenous nonthoracotomy cardioverter defibrillator systems and permanent transvenous endocardial pacemakers.
Geiger MJ; O'Neill P; Sharma A; Skadsen A; Zimerman L; Greenfield RA; Newby KH; Wharton JM; Kent V; Natale A
Pacing Clin Electrophysiol; 1997 Mar; 20(3 Pt 1):624-30. PubMed ID: 9080488
[TBL] [Abstract][Full Text] [Related]
18. Treating or Killing? The Divergent Moral Implications of Cardiac Device Deactivation.
Pilkington BC
J Med Philos; 2020 Jan; 45(1):28-41. PubMed ID: 31889187
[TBL] [Abstract][Full Text] [Related]
19. Octo- and nonagenarians' outlook on life and death when living with an implantable cardioverter defibrillator: a cross-sectional study.
Thylén I; Moser DK; Strömberg A
BMC Geriatr; 2018 Oct; 18(1):250. PubMed ID: 30342484
[TBL] [Abstract][Full Text] [Related]
20. An up-to-date review of cardiac pacemakers and implantable cardioverter defibrillators.
Kuang RJ; Pirakalathanan J; Lau T; Koh D; Kotschet E; Ko B; Lau KK
J Med Imaging Radiat Oncol; 2021 Dec; 65(7):896-903. PubMed ID: 34472707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
